ReviewAAPS PharmSciTech2025
Dissolvable Microneedles with Their Design, Materials, and Limitations in Translation: a Technical Review.
Review in AAPS PharmSciTech, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Dissolving microneedles for inflammatory diseases: Advances in formulation strategies and therapeutic applications.International journal of pharmaceutics: X · 2026Review
- Microarray patches as a potential alternative to injectable fertility medications: a qualitative study of patients' and healthcare professionals' perceptions.International journal of clinical pharmacy · 2026Article
- Review
- Tower-shaped super-adhesive microneedles loaded with vitamin A-containing Bletilla striata vesicles: temporally regulated Inflammation resolution and ECM remodeling for scarless wound healing.Journal of nanobiotechnology · 2026Article
- Advanced Sensing and Delivery Technologies for Nose-to-Brain Administration: From Nanocarriers to Sensor-Integrated Organ-on-Chips.Sensors (Basel, Switzerland) · 2026Review
- Biosensor-Integrated Microneedle Devices for Diagnosis and Treatment of Chronic and Infectious Diseases: Current Status, Trends and Challenges.Biosensors · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dissolvable microneedles (DMNs) have emerged as a groundbreaking drug delivery platform, offering a minimally invasive alternative to conventional parenteral and oral administration while enabling precise, pain-free, and patient-friendly therapeutic delivery. This review provides a comprehensive technical overview of the design, materials, and translational challenges of DMN systems. We begin by examining critical design parameters, including microneedle geometry, array configuration, mechanical strength, and drug distribution, that directly influence insertion efficiency, structural integrity, and dissolution kinetics. The role of mathematical modeling in optimizing DMN performance is also explored, offering insights into drug diffusion, structural mechanics, and dissolution kinetics. The materials section highlights the diverse natural and synthetic polymers used in DMN fabrication, along with additives and stabilizers that modulate drug release, improve biocompatibility, and ensure formulation stability. Despite significant advances in preclinical research, the translation of DMNs into clinical and commercial applications remains hindered by several factors, including limitations in drug loading capacity, manufacturing scalability, dose precision, long-term storage stability, and regulatory complexity. We also explore user-centric challenges, including ease of administration, patient compliance, and cost-effectiveness. The final section discusses current strategies to address these barriers, including the use of smart and stimuli-responsive polymers, next-generation microfabrication techniques, and packaging innovations designed to enhance shelf life and user handling. Through this, we aim to provide a critical perspective on the design, materials, and future potential of DMN technology, charting a path toward its successful integration into mainstream healthcare systems.
Indexed as
Identifiers
41184649What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.